Prescott General Partners »

Lineage Cell Therapeutics In shares owned by Prescott General Partners

Quarter-by-quarter ownership of Lineage Cell Therapeutics In (LCTX) shares owned by Prescott General Partners from 13F filings

Historical chart of Prescott General Partners investment in Lineage Cell Therapeutics In

Tip: Access up to 7 years of quarterly data

All positions including Lineage Cell Therapeutics In held by Prescott General Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Lineage Cell Therapeutics In by Prescott General Partners

Quarter filed Position value Share count Share price at filing
2023-12-31 $2.0M 1.9M 1.09
2023-09-30 $2.2M 1.9M 1.18
2023-06-30 $2.6M 1.9M 1.41
2023-03-31 $2.8M 1.9M 1.50
2022-12-31 $2.2M 1.9M 1.17
2022-09-30 $2.1M 1.9M 1.13
2022-06-30 $2.9M 1.9M 1.58
2022-03-31 $2.9M 1.9M 1.54
2021-12-31 $4.5M 1.9M 2.45
2021-09-30 $4.7M 1.9M 2.52
2021-06-30 $5.3M 1.9M 2.85
2021-03-31 $4.4M 1.9M 2.35
2020-12-31 $3.3M 1.9M 1.76
2020-09-30 $1.7M 1.9M 0.94
2020-06-30 $1.6M 1.9M 0.87
2020-03-31 $1.5M 1.9M 0.83
2019-12-31 $1.6M 1.9M 0.89
2019-09-30 $1.8M 1.9M 0.98